CERAGON NETWORKS LTD (CRNT) Fundamental Analysis & Valuation

NASDAQ:CRNT • IL0010851660

Current stock price

2.31 USD
+0.01 (+0.43%)
Last:

This CRNT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. CRNT Profitability Analysis

1.1 Basic Checks

  • CRNT had positive earnings in the past year.
  • In the past year CRNT had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: CRNT reported negative net income in multiple years.
  • The reported operating cash flow has been mixed in the past 5 years: CRNT reported negative operating cash flow in multiple years.
CRNT Yearly Net Income VS EBIT VS OCF VS FCFCRNT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

  • The Return On Assets of CRNT (0.43%) is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of 0.81%, CRNT is in line with its industry, outperforming 58.33% of the companies in the same industry.
  • CRNT has a better Return On Invested Capital (6.90%) than 79.17% of its industry peers.
Industry RankSector Rank
ROA 0.43%
ROE 0.81%
ROIC 6.9%
ROA(3y)0.75%
ROA(5y)-1.82%
ROE(3y)0.89%
ROE(5y)-3.97%
ROIC(3y)N/A
ROIC(5y)N/A
CRNT Yearly ROA, ROE, ROICCRNT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10

1.3 Margins

  • CRNT has a Profit Margin of 0.38%. This is comparable to the rest of the industry: CRNT outperforms 54.17% of its industry peers.
  • CRNT has a better Operating Margin (6.32%) than 72.92% of its industry peers.
  • CRNT's Operating Margin has improved in the last couple of years.
  • The Gross Margin of CRNT (34.98%) is worse than 62.50% of its industry peers.
  • CRNT's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.32%
PM (TTM) 0.38%
GM 34.98%
OM growth 3Y71.41%
OM growth 5Y22.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.77%
GM growth 5Y0.06%
CRNT Yearly Profit, Operating, Gross MarginsCRNT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30

3

2. CRNT Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CRNT is destroying value.
  • There is no outstanding debt for CRNT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CRNT Yearly Shares OutstandingCRNT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
CRNT Yearly Total Debt VS Total AssetsCRNT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • CRNT has an Altman-Z score of 1.45. This is a bad value and indicates that CRNT is not financially healthy and even has some risk of bankruptcy.
  • CRNT's Altman-Z score of 1.45 is in line compared to the rest of the industry. CRNT outperforms 52.08% of its industry peers.
  • The Debt to FCF ratio of CRNT is 7.68, which is on the high side as it means it would take CRNT, 7.68 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 7.68, CRNT is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • CRNT has a Debt/Equity ratio of 0.18. This is a healthy value indicating a solid balance between debt and equity.
  • With a Debt to Equity ratio value of 0.18, CRNT perfoms like the industry average, outperforming 43.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 7.68
Altman-Z 1.45
ROIC/WACC0.74
WACC9.29%
CRNT Yearly LT Debt VS Equity VS FCFCRNT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

  • CRNT has a Current Ratio of 1.81. This is a normal value and indicates that CRNT is financially healthy and should not expect problems in meeting its short term obligations.
  • CRNT's Current ratio of 1.81 is on the low side compared to the rest of the industry. CRNT is outperformed by 60.42% of its industry peers.
  • A Quick Ratio of 1.36 indicates that CRNT should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.36, CRNT is doing worse than 62.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.36
CRNT Yearly Current Assets VS Current LiabilitesCRNT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2

3. CRNT Growth Analysis

3.1 Past

  • The earnings per share for CRNT have decreased strongly by -75.61% in the last year.
EPS 1Y (TTM)-75.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.78%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-23.01%

3.2 Future

  • CRNT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 48.34% yearly.
  • CRNT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.84% yearly.
EPS Next Y65.75%
EPS Next 2Y50.56%
EPS Next 3Y48.34%
EPS Next 5YN/A
Revenue Next Year7.26%
Revenue Next 2Y6.84%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

CRNT Yearly Revenue VS EstimatesCRNT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
CRNT Yearly EPS VS EstimatesCRNT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.1 -0.1 0.2 0.3 0.4

6

4. CRNT Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 23.10 indicates a rather expensive valuation of CRNT.
  • 70.83% of the companies in the same industry are more expensive than CRNT, based on the Price/Earnings ratio.
  • When comparing the Price/Earnings ratio of CRNT to the average of the S&P500 Index (25.50), we can say CRNT is valued inline with the index average.
  • CRNT is valuated correctly with a Price/Forward Earnings ratio of 13.94.
  • 91.67% of the companies in the same industry are more expensive than CRNT, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of CRNT to the average of the S&P500 Index (22.67), we can say CRNT is valued slightly cheaper.
Industry RankSector Rank
PE 23.1
Fwd PE 13.94
CRNT Price Earnings VS Forward Price EarningsCRNT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, CRNT is valued cheaply inside the industry as 97.92% of the companies are valued more expensively.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CRNT is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 51.41
EV/EBITDA 4.47
CRNT Per share dataCRNT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as CRNT's earnings are expected to grow with 48.34% in the coming years.
PEG (NY)0.35
PEG (5Y)N/A
EPS Next 2Y50.56%
EPS Next 3Y48.34%

0

5. CRNT Dividend Analysis

5.1 Amount

  • No dividends for CRNT!.
Industry RankSector Rank
Dividend Yield 0%

CRNT Fundamentals: All Metrics, Ratios and Statistics

CERAGON NETWORKS LTD

NASDAQ:CRNT (3/25/2026, 4:30:00 PM)

2.31

+0.01 (+0.43%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)02-17
Earnings (Next)05-05
Inst Owners19.3%
Inst Owner Change-7.56%
Ins Owners13.85%
Ins Owner Change0%
Market Cap207.65M
Revenue(TTM)N/A
Net Income(TTM)1.39M
Analysts81.82
Price Target4.85 (109.96%)
Short Float %0.29%
Short Ratio0.45
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-30.52%
Min EPS beat(2)-35.18%
Max EPS beat(2)-25.86%
EPS beat(4)1
Avg EPS beat(4)-12.46%
Min EPS beat(4)-35.18%
Max EPS beat(4)17.65%
EPS beat(8)4
Avg EPS beat(8)4.5%
EPS beat(12)6
Avg EPS beat(12)8.41%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-5.56%
Min Revenue beat(2)-11.53%
Max Revenue beat(2)0.4%
Revenue beat(4)2
Avg Revenue beat(4)-2.82%
Min Revenue beat(4)-11.53%
Max Revenue beat(4)0.4%
Revenue beat(8)3
Avg Revenue beat(8)-1.75%
Revenue beat(12)6
Avg Revenue beat(12)-0.89%
Revenue beat(16)6
Avg Revenue beat(16)-1.33%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-10.47%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-2.61%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.65%
Valuation
Industry RankSector Rank
PE 23.1
Fwd PE 13.94
P/S 0.57
P/FCF 51.41
P/OCF 9.59
P/B 1.21
P/tB 1.5
EV/EBITDA 4.47
EPS(TTM)0.1
EY4.33%
EPS(NY)0.17
Fwd EY7.18%
FCF(TTM)0.04
FCFY1.95%
OCF(TTM)0.24
OCFY10.43%
SpS4.04
BVpS1.91
TBVpS1.54
PEG (NY)0.35
PEG (5Y)N/A
Graham Number2.08
Profitability
Industry RankSector Rank
ROA 0.43%
ROE 0.81%
ROCE 11.64%
ROIC 6.9%
ROICexc 8.5%
ROICexgc 10.39%
OM 6.32%
PM (TTM) 0.38%
GM 34.98%
FCFM 1.11%
ROA(3y)0.75%
ROA(5y)-1.82%
ROE(3y)0.89%
ROE(5y)-3.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y93.38%
ROICexgc growth 5Y31.98%
ROICexc growth 3Y86.61%
ROICexc growth 5Y29.42%
OM growth 3Y71.41%
OM growth 5Y22.33%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.77%
GM growth 5Y0.06%
F-Score5
Asset Turnover1.11
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF 7.68
Debt/EBITDA 0.85
Cap/Depr 129.1%
Cap/Sales 4.85%
Interest Coverage 250
Cash Conversion 59.18%
Profit Quality 290.37%
Current Ratio 1.81
Quick Ratio 1.36
Altman-Z 1.45
F-Score5
WACC9.29%
ROIC/WACC0.74
Cap/Depr(3y)125.95%
Cap/Depr(5y)101.34%
Cap/Sales(3y)4.03%
Cap/Sales(5y)3.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-75.61%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-77.78%
EPS Next Y65.75%
EPS Next 2Y50.56%
EPS Next 3Y48.34%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-23.01%
Revenue Next Year7.26%
Revenue Next 2Y6.84%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-41.62%
EBIT growth 3Y89.71%
EBIT growth 5Y30.47%
EBIT Next Year-27.61%
EBIT Next 3Y1.21%
EBIT Next 5YN/A
FCF growth 1Y1102.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y89.73%
OCF growth 3YN/A
OCF growth 5YN/A

CERAGON NETWORKS LTD / CRNT Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CERAGON NETWORKS LTD (CRNT) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CRNT.


What is the valuation status for CRNT stock?

ChartMill assigns a valuation rating of 6 / 10 to CERAGON NETWORKS LTD (CRNT). This can be considered as Fairly Valued.


Can you provide the profitability details for CERAGON NETWORKS LTD?

CERAGON NETWORKS LTD (CRNT) has a profitability rating of 4 / 10.


Can you provide the financial health for CRNT stock?

The financial health rating of CERAGON NETWORKS LTD (CRNT) is 3 / 10.


What is the expected EPS growth for CERAGON NETWORKS LTD (CRNT) stock?

The Earnings per Share (EPS) of CERAGON NETWORKS LTD (CRNT) is expected to grow by 65.75% in the next year.